Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
Phase 1B/II Study of Escalating Doses of Pevonedistat (TAK-924, Formerly MLN4924) Administered in Combination with Standard Induction Chemotherapy (Cytarabine and Idarubicin) in Newly Diagnosed ....
Sponsored by University of Southern California
Active
$62.9K Funding
1 People
External
Related Topics
cancer treatment,
chemotherapy,
clinical trial,
drug combination,
leukemia
People
Jennifer Carew
Principal Investigator (PI)
Medicine
﹒Professor
